IL-15 has been found to co-localize within the tumor microenvironment with cluster of differentiation (CD)8+ T and NK cells [18], and the injection of IL-15 suppressed tumor burden by increasing intratumoral CD8+ T and NK cells in a mouse model [19]. This evidence concerns the gene CD8A and neoplasm.